COVID-19 (coronavirus) and RSV vaccines for people with Crohn's or Colitis, the two main form of Inflammatory Bowel Disease, ...

People living with Crohn's or Colitis may have a slightly higher risk of developing some types of cancer than those in the general population. Cancer treatment is more likely to be successful if the ...

Giving a gift in memory of a loved one is a very special way to remember them. By honouring their memory and supporting a charity that was close to them during their lifetime, you are helping ...

No one knows your Crohn’s or Colitis like you do, but it can be hard to talk about it. Our Talking Toolkit is here to help you find the right words to share what you’re going through. Whoever you want ...

Explore the research we have funded, ranging from medical studies investigating new treatments and the causes of pain, to projects into the psychological and social aspects of living with Crohn’s and ...

The RSFC has broad representation from all health disciplines within the inflammatory bowel disease (IBD) specialty along with representatives from the Board of Trustees and individuals with lived ...

02 November 2024 | 10:00-12:00 | Marks and Spencer's Café XL (Second floor), Westfield Stratford City, Olympic Park, Montifichet Road, London, E20 1EJ ...

Thank you for choosing to fundraise for Crohn’s and Colitis UK, we're incredibly grateful to have you on our team. Remember, no matter what you choose to do, whether it’s sporting a daring hair-do, ...

We know it can be difficult to live with, or support someone living with these conditions. But you’re not alone. We provide up-to-date, evidence-based information and can support you to live well with ...

From September 2024, biosimilar versions of ustekinumab will become available in the UK. This is happening because the patent for Stelara, the brand name for the original ustekinumab, ran out in July.